Member Network Leverage BIA's 600+ member companies, including startups, pharma and universities, to access senior decision-makers across biotech and life sciences in the UK. Opportunities for co-hosted events, sponsored content, and targeted outreach via the association's channels.

BioSolutions Platform With the launch of BIA BioSolutions, a dedicated platform for the UK's fast-growing bioeconomy and engineering biology, there is an opening to offer services that align with platform initiatives such as data analytics, regulatory tools, training modules, or sponsorship opportunities to reach platform participants.

Clinical Trial Focus Recent actions around Blood Cancer Action Plan and HIV vaccine work show BIA's emphasis on improving access to clinical trials and reducing barriers for underrepresented groups. Sales opportunities include trial recruitment services, patient engagement software, data analytics for trials, and partnerships with CROs and biotech developers to support trial infrastructure.

Public Health Engagement Regular collaboration with public health initiatives indicates access to public-sector programs and procurement channels. Potential to offer policy consulting, market access planning, regulatory affairs, and health economics support to member companies targeting government-funded programs.

Funding Support Historical non-dilutive funding and in vivo proof-of-concept achievements suggest demand for grant strategy and financial planning. Potential to provide grant writing, funding advisory, financial modeling, and grant management tools or advisory services to BIA and its members.